Biogen Inc. buy Royal Bank of Canada
Start price
07.04.26
/
50%
€149.80
Target price
07.04.27
€184.73
Performance (%)
22.43%
Price
09:53
€183.40
Summary
This prediction is currently active. The prediction currently has a performance of 22.43%. This prediction currently runs until 07.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 2.033% | 2.033% |
| iShares Core DAX® | 0.881% | 5.632% |
| iShares Nasdaq 100 | 2.390% | 1.571% |
| iShares Nikkei 225® | 4.269% | 2.521% |
| iShares S&P 500 | 1.171% | 2.545% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (BIIB) had its price target lowered by Royal Bank Of Canada from $233.00 to $213.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat